The Pharmacoepidemiology of Selective Serotonin Reuptake Inhibitors for Children and Adolescents in Canada from 2005 to 2009: A Database Analysis

被引：0
|
作者：
Darren Lam
Daniel A. Gorman
Scott Patten
Tamara Pringsheim
机构：
[1] University of Calgary,Department of Clinical Neurosciences Psychiatry, and Pediatrics
[2] C4-431,Department of Psychiatry
[3] Alberta Children’s Hospital,Department of Community Health Sciences and Psychiatry
[4] University of Toronto,undefined
[5] University of Calgary,undefined
来源：
Pediatric Drugs | 2013年 / 15卷
关键词：
Major Depressive Disorder; Fluoxetine; Paroxetine; Escitalopram; Canadian Youth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：319 / 327
页数：8
相关论文
共 50 条
  • [21] The problems involved in administration of selective serotonin reuptake inhibitors to depressed children and adolescents
    Fegert, JM
    Herpertz-Dahlmann, B
    NERVENARZT, 2004, 75 (09): : 908 - +
  • [22] Selective Serotonin Reuptake Inhibitors (SSRIs) and Hyperprolactinemia: Analysis of the French Pharmacovigilance Database
    Oger, F.
    Buire, A. C.
    Trenque, T.
    DRUG SAFETY, 2008, 31 (10) : 932 - 932
  • [23] Selective serotonin Reuptake Inhibitors (SSRIs) and Hyperprolactinemia: Analysis of the French Pharmacovigilance Database
    F. Oger
    A. C. Buire
    T. Trenque
    Drug Safety, 2008, 31 : 885 - 885
  • [24] Selective Serotonin Reuptake Inhibitors and Venous Thromboembolism: a Pharmacovigilance Analysis of the Eudravigilance Database
    Lopes, Andreia
    Prada, Luisa
    Avo-Baiao, Rita
    Fernandes, Joao
    Silva, Marcia
    DRUG SAFETY, 2024, 47 (12) : 1409 - 1409
  • [25] Selective serotonin reuptake inhibitors (SSRI's) are not indicated for depressive children and adolescents.
    Treffers, DA
    Rinne-Albers, MAW
    NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE, 2005, 149 (24) : 1314 - 1317
  • [26] Safety and efficacy of selective serotonin reuptake inhibitors in the treatment of children and adolescents compared to adults
    Aichhorn, AW
    Geretsegger, C
    NEUROPSYCHIATRIE, 2005, 19 (01) : 34 - 39
  • [27] Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents
    Sun, Jenny W.
    Hernandez-Diaz, Sonia
    Haneuse, Sebastien
    Bourgeois, Florence T.
    Vine, Seanna M.
    Olfson, Mark
    Bateman, Brian T.
    Huybrechts, Krista F.
    JAMA PSYCHIATRY, 2021, 78 (01) : 91 - 100
  • [28] Efficacy and adverse effects of selective serotonin reuptake inhibitors in children and adolescents with depression and epilepsy
    Thome-Souza, S
    Kuczynski, E
    Assumpcao, FB
    Fiore, LA
    Valente, KD
    EPILEPSIA, 2004, 45 : 277 - 277
  • [29] Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors
    Joseph, Megan F.
    Youngstrom, Eric A.
    Soares, Jair C.
    FUTURE NEUROLOGY, 2009, 4 (01) : 87 - 102
  • [30] Selective serotonin reuptake inhibitors (SSRIs) in children and adolescents with obsessive compulsive disorder (OCD).
    Heyman, I
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A8 - A8
12345